Experimental lung wash aims to save ventilated COVID patients
NCT ID NCT04725110
Summary
This study aimed to test whether putting a medication called T3 directly into the lungs could help people with severe COVID-19 who were on a ventilator. It planned to enroll patients with life-threatening breathing failure (ARDS) to see if the treatment could reduce dangerous fluid in the lungs, shorten ICU stays, and improve survival. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55117, United States
Conditions
Explore the condition pages connected to this study.